| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |